---
layout: post
title: EmgalityÂ® for migraine
category: note
tags: protocols
---

<p class="largetype">EmgalityÂ® for migraine </p>

Protocol: **Anti CGRP migraine treatments for patients refractory to standard therapy**  
Subscription: **$10/month + cost of meds**    
Creator: **[Dr. Sam Smith MD](https://github.com/sparanoid/almace-scaffolding)**  
Tags: `migraine`, `cgrp`, `emgality`, `neuro`  
Status:<span style="color: #4AFF33"> â— Accepting new patients</span>

<!--<p style="color: #fc9003">â— Not accepting patients</p>

<p style="color: #999999">â— Discontinued</p>-->

## Summary

CGRP migraine treatment is a new type of treatment used to prevent and treat migraine pain. The medication blocks a protein called calcitonin gene-related peptide (CGRP). CGRP may cause inflammation and pain in the nervous system of people who have migraine attacks. This protocol is *for patients who are refractory to existing treatments and are comfortable using pen injectors on themselves*.

## Formulary 

AimovigÂ® (erenumab-aooe) 70mg/ml pen injector ğŸ’‰  
AimovigÂ® (erenumab-aooe) 140mg/ml pen injector ğŸ’‰  
AjovyÂ® 225 mg/ml (fremanezumab) pen injector ğŸ’‰  
EmgalityÂ® 120 mg/ml (galcanezumab-gnlm) pen injector ğŸ’‰  
Ubrelyâ„¢ (ubrogepant) 50mg tablet ğŸ’Š  
Ubrelyâ„¢ (ubrogepant) 100mg tablet ğŸ’Š  

## Eligibility 

Existing history of migraine refractory to standard treatment (e.g. NSAIDS, sumatriptan, etc). Not currently pregnant or soon to be pregnant. Generally well. Ages 18 to 64. Additional restrictions apply. 

## Availability

This protocol is available in the following states:

California  
New York  
Texas  
Virgina  


<br>
<p class="largetype">
  <a href="{{ '/getting-started.html' | relative_url }}">Subscribe â†’</a>
</p>
